Showing results (1-10 of 90) with videos related to
Sort By:
Pageof 9
Anti-Cancer Drugs|August 1, 1997
Down-regulation of topoisomerase II by camptothecin does not prevent additive activity of the topoisomerase II inhibitor etoposide in vitroM Stahl, S Kasimir-Bauer, A HarstrickInternational Journal of Andrology|February 1, 1987
Comparative antitumour activity of cisplatin and two new cisplatin-analogues JM8 and JM9 in human testicular carcinoma xenograftsA Harstrick, J Casper, H J SchmollSeminars in Oncology|February 1, 1996
Preclinical and clinical study results of the combination of paclitaxel and 5-fluorouracil/folinic acid in the treatment of metastatic breast cancerU Klaassen, A Harstrick, H Wilke, et al.Seminars in Oncology|April 1, 1992
Modulation of fluoropyrimidines: role of dose and schedule of leucovorin administrationZ G Zhang, A Harstrick, Y M RustumOncology (Williston Park, N.Y.)|March 28, 1998
Fluorouracil-based combinations in the treatment of metastatic breast cancerU Klaassen, H Wilke, A Harstrick, et al.European Journal of Cancer (Oxford, England : 1990)|January 25, 2000
Raltitrexed (Tomudex) in combination with 5-fluorouracil for the treatment of patients with advanced colorectal cancer: preliminary results from phase I clinical trialsG K Schwartz, A Harstrick, M González BarónSeminars in Oncology|April 1, 1992
Mechanisms of resistance to fluoropyrimidinesZ G Zhang, A Harstrick, Y M RustumThe Journal of Bone and Joint Surgery. British Volume|November 1, 1996
Cytotoxicity of phenol to musculoskeletal tumoursU Quint, U Vanhöfer, A Harstrick, et al.Seminars in Oncology|March 4, 2000
Ifosfamide-based drug combinations: preclinical evaluation of drug interactions and translation into the clinicU Vanhoefer, N Schleucher, U Klaassen, et al.Pageof 9